Works matching IS 01676997 AND DT 2019 AND VI 37 AND IP 5


Results: 29
    1
    2
    3
    4
    5

    A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 5, p. 1052, doi. 10.1007/s10637-019-00731-5
    By:
    • McHugh, Deaglan;
    • Eisenberger, Mario;
    • Heath, Elisabeth I.;
    • Bruce, Justine;
    • Danila, Daniel C.;
    • Rathkopf, Dana E.;
    • Feldman, Jarett;
    • Slovin, Susan F.;
    • Anand, Banmeet;
    • Chu, Rong;
    • Lackey, Jacqueline;
    • Reyno, Leonard;
    • Antonarakis, Emmanuel S.;
    • Morris, Michael J.
    Publication type:
    Article
    6
    7

    Human antigen R and drug resistance in tumors.

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 5, p. 1107, doi. 10.1007/s10637-018-00723-x
    By:
    • Zhou, Fenghai;
    • Zhang, Fa;
    • Zhou, Chuan;
    • Liang, Mengtian;
    • Cai, Zhonglin;
    • Lv, Haidi;
    • Li, Wenjuan;
    • Wei, Xupan
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer.

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 5, p. 818, doi. 10.1007/s10637-018-0686-6
    By:
    • Yokoi, Eriko;
    • Mabuchi, Seiji;
    • Shimura, Kotaro;
    • Komura, Naoko;
    • Kozasa, Katsumi;
    • Kuroda, Hiromasa;
    • Takahashi, Ryoko;
    • Sasano, Tomoyuki;
    • Kawano, Mahiru;
    • Matsumoto, Yuri;
    • Kodama, Michiko;
    • Hashimoto, Kae;
    • Sawada, Kenjiro;
    • Kimura, Tadashi
    Publication type:
    Article
    26
    27
    28
    29